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ABSTRACT 
 This paper investigates possible synthetic pathways for two 2-thio-
substituted-3H-phenothiazin-3-ones (7). A two step reaction in which 1,4-benzoquinone 
(1) is first reacted with an alkylthiol (2) in the presence of sodium periodate (NaIO4) and 
then treated with 2-aminothiophenol (5) followed by a second oxidation with sodium 
periodate was demonstrated to be effective in synthesizing 2-(phenylthio)-3H-
phenothiazin-3-one (12). The same synthetic approach was shown to be ineffective in 
the synthesis of 2-(cyclopentylthio)-3H-phenothiazin-3-one (16) due to the fact that the 
first step was incapable of synthesizing 2-(cyclopentylthio)-1,4-benzoquinone (14). 
Several other synthetic routes were also proven to be ineffective. This investigation is 
part of a larger effort to create a vast library of 2-thio-substituted-3H-phenothiazin-3-
ones (7) for testing in leukotriene inhibition and treatment of neurodegenerative 
disorders. 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INTRODUCTION 
 According to Girard et al., work on derivatives of phenothiazine have historically 
led to the development of drugs capable of treating central nervous system (CNS) 
disorders.1 Examples of these drugs include Ethopropazine, an anti-Parkinson drug, 
and Chlorpromazine, an early anti-psychotic.1 Observations in their lab have also 
indicated that derivatives of 3H-phenothiazin-3-one, which have since been 
demonstrated effective in the treatment of neurodegenerative disorders2, also have the 
potential to treat diseases caused by leukotrienes.1 Leukotrienes are classic mediators 
of inflammation3  produced by leukocytes and other immune cells.4 Their inflammatory 
effects are most notably thought to play a role in asthma5 and allergic rhinitis,6 but 
leukotriene-mediated inflammation also plays a significant role in inflammatory 
conditions ranging from conjunctivitis7 to traumatic brain injury.8 Fortin et al. have 
concluded that work on inhibition of leukotriene biosynthesis and/or antagonism of 
leukotriene action will remarkably benefit the range of patients suffering from 
leukotriene-mediated diseases.9 In the present paper, we aim to describe our work 
towards synthesizing two 2-thio-substituted-3H-phenothiazin-3-ones (7) in preparation 
for testing their efficacy in the inhibition of leukotrienes and treatment of 
neurodegenerative disorders.  
 The initially proposed dual step synthetic approach for both molecules (Figure 1) 
adapted from previous work done on the compilation of this molecular library10 follows 
two steps. First, the 2-alkylthio-1,4-benzoquinone (3) would be formed by reacting 1,4-
benzoquinone (1) with an alkylthiol (2) in the presence of sodium periodate (NaIO4) and 
distilled water. Second, the 2-thio-substituted-3H-phenothiazin-3-one (7) would be 
formed by reacting 2-alkylthio-1,4-benzoquinone (3) with 2-aminothiophenol (5) in the 
presence of sodium periodate and distilled water. 
 The initially proposed dual step synthetic approach worked well for 2-
(phenylthio)-3H-phenothiazin-3-one (12). First, the 2-(phenylthio)-1,4-benzoquinone (9) 
was formed by reacting 1,4-benzoquinone (1) with thiophenol (8) in the presence of 
sodium periodate and distilled water. Second, 2-(phenylthio)-3H-phenothiazin-3-one 
(12) was formed by reacting 2-(phenylthio)-1,4-benzoquinone (9) with 2-
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aminothiophenol (5) in the presence of sodium periodate in distilled water as shown in 
Figure 2. 
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Figure 1. Initially proposed dual step approach to synthesizing 2-thio-substituted-3H-
phenothiazin-3-ones 
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Figure 2. Initially proposed dual step approach to synthesizing 2-(phenylthio)-3H-
phenothiazin-3-one
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 No 2-(cyclopentylthio)-1,4-benzoquinone (14) was able to be formed, however, 
when the initially proposed dual step synthetic approach (Figure 3) was applied to the 
formation of 2-(cyclopentylthio)-3H-phenothiazin-3-one (Figure 4). A new synthetic 
approach for 2-(cyclopentylthio)-1,4-benzoquinone (14), therefore, had to be devised. 
 The second proposed synthetic approach for 2-(cyclopentylthio)-1,4-
benzoquinone (14) follows two steps (Figure 5). First, 2-(cyclopentylthio)-hydroquinone 
(18) would be formed by attacking 1,4-benzoquinone (1) with thiocyclopentane (13) 
deprotonated by sodium tert-butoxide. Second, the 2-(cyclopentylthio)-3H-hydroquinone 
(18) would be oxidized using sodium periodate to form 2-(cyclopentylthio)-1,4-
benzoquinone (14). This procedure resulted in a bis-alkylation of benzoquinone and had 
to be abandoned as well.  
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Figure 3. First step of initially proposed dual step approach to synthesizing 2-
(cyclopentylthio)-3H-phenothiazin-3-one
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Figure 4. 2-(cyclopentylthio)-3H-phenothiazin-3-one
16
Step 1
Step 2
Figure 5. Second proposed approach to synthesizing 2-(cyclopentylthio)-1,4-benzoquinone
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 The third proposed synthetic approach for 2-(cyclopentylthio)-1,4-benzoquinone 
(14) follows a single step (Figure 6). The 2-(cyclopentylthio)-1,4-benzoquinone (14) 
would be formed by performing an addition-elimination reaction between 2-chloro-1,4-
benzoquinone (19) and thiocyclopentane (13) deprotonated by sodium tert-butoxide. 
The third synthetic approach resulted in the formation of new product but requires 
further purification and identification by NMR to establish its success.  
EQUIPMENT AND METHODOLOGY 
Synthesis of 2-(phenylthio)-3H-phenothiazin-3-one - Initially Proposed Dual Step 
Synthetic Approach - Step I 
 To synthesize 2-(phenylthio)-1,4-benzoquinone (9), 0.2703 g of 1,4-
benzoquinone (1) were added to 12.50 mL of dichloromethane (DCM) and 2.50 mL of 
methanol (MeOH). Then, 0.0256 mL of the thiophenol (8) were added to the reaction 
vessel using a 500um Hamilton precision syringe. In a separate reaction vessel, 1.069 g 
of sodium periodate were added to 5.00 mL of distilled water and then poured drop-wise 
into the main reaction vessel. The main reaction vessel was then shaken gently for 
about thirty seconds, a stir-bar was added, and the reaction vessel was placed on the 
stir plate (CG-1994 Chemglass Optimag Magnetic Hot Plate Stirrer) at 350 RPM and 
room temperature (r.t.) overnight. The reaction was monitored with a ten-minute thin-
layer chromatography (TLC) using a 7:3 hexanes:ethyl acetate (H:E) under 254 nm 
ultra-violet (UV) light to confirm the formation of a new compound (Figure 7A). The next 
day, the solid was extracted from the reaction solution using the extraction procedure 
outlined below. The dried crude was then placed in a refrigerator for storage. The 
following week, the desired product was isolated using the flash column 
!6
19 13 14
Figure 6. Third proposed approach to synthesizing 2-(cyclopentylthio)-1,4-benzoquinone
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chromatography procedure defined below with a 95:5 hexanes:ethyl acetate solvent 
system. Fractions 8-34 were collected, and the solvent is then stripped under reduced 
pressure and heat (WG-HB03 Wilmad LabGlass Heat Bath) in a rotary evaporator 
(RE11 Buchi Rotavapor). Finally, the isolated 2-(phenylthio)-1,4-benzoquinone (12) was 
refrigerated. The identity of final product was successfully confirmed using 1H NMR (400 
Hz Jeol FT-NMR). 
Synthesis of 2-(phenylthio)-3H-phenothiazin-3-one - Initially Proposed Dual Step 
Synthetic Approach - Step II 
 To synthesize 2-(phenylthio)-3H-phenothiazin-3-one (12), 0.025 mL of 2-
aminothiophenol (5) were added to 0.0491 g of 2-(phenylthio)-1,4-benzoquinone (10) in 
1.14 mL DCM and 0.227 mL of MeOH. In a separate reaction vessel, 0.097 g of sodium 
periodate were added to 0.455 mL of distilled water and then poured drop-wise into the 
main reaction vessel. The main reaction vessel was then shaken gently for about thirty 
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Figure 7. Ten minute thin-layer chromatography plates. In each frame, 
column 1 represents starting material. Columns 2 and 3 show new product. 
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seconds, a stir-bar was added, and the reaction vessel was placed on the stir plate at 
350 RPM and r.t. overnight. The reaction was monitored with a ten-minute TLC with a 
99:1:0.1 DCM:methanol:ammonia (D:M:A) solvent system to establish the formation of a 
new compound (Figure 7B). The next day, the solid was extracted, and the dried crude 
was placed in a refrigerator for storage. The following week, the desired product was 
isolated using the preparative TLC procedure outlined below with a 99:1:0.1 
DCM:MeOH:ammonia solvent system (Figure 8). The identity of the final product was 
later confirmed using 1H NMR. 
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Figure 8. Preparative TLC (500um 20x20cm) run with 99:1:0.1 
DCM:MeOH:ammonia solvent to isolate 2-(phenylthio)-3H-phenothiozin-3-
one. Desired band indicated by black boxes.
Synthesis of 2-(cyclopentylthio)-3H-phenothiazin-3-one - Initially Proposed Dual 
Step Synthetic Approach - Step I 
 In accordance with the first step of the proposed general synthetic approach, 
0.2703 g of 1,4-benzoquinone (1) were added to a reaction vessel containing 12.50 mL 
of DCM and 2.50 mL of MeOH. Next, 0.267 mL of 97% cyclopentanethiol (13) were 
added to the reaction vessel using a 500 uL Hamilton precision syringe. In a separate 
reaction vessel, 1.069 g of sodium periodate were added to 5.00 mL of distilled water. 
This mixture was then added to the main reaction vessel drop-wise. The entire reaction 
was shaken gently for about 30 seconds, a stir bar was added, and the reaction was 
monitored with a ten-minute TLC with a 99:1:0.1 DCM:methanol:ammonia solvent 
system under 254 nm ultra-violet (UV) light to establish the formation of a new 
compound (Figure 7C). The reaction vessel was placed on the stir plate running at 350 
RPM at r.t. overnight. The next day, the crude was extracted using the extraction 
procedure and refrigerated. One week later, a flash chromatography column was run 
using a 95:5 hexanes:ethyl acetate solvent system. Fractions 5-13 were collected, 
stripped, and the purified product was refrigerated. The identity of the final product was 
later investigated using 1H NMR.  
Synthesis of 2-(cyclopentylthio)-1,4-benzoquinone - Second Proposed Synthetic 
Approach - Step I 
 First, 0.072 g of sodium metal (Na) were added to 8.33 mL of 2-methyl-2-
propanol (17), a stir bar was added, and the reaction was stirred on a hot plate (Isotemp 
Fisher Scientific) for 1 hour under gentle heat (~100oC) and 350 RPM. Then, 0.267 mL 
of the 97% cyclopentanethiol (13) were added to the reaction vessel using a 500 um 
Hamilton precision syringe, and the reaction was stirred for another hour under gentle 
heat at 350 RPM. Finally, 0.2703 g of 1,4-benzoquinone (1) were added, and the 
reaction was then left on the stir plate to stir at 350 RPM at r.t. for five days. After five 
days the reaction vessel was refrigerated. Two days later, the reaction vessel was 
gently thawed and 0.090 mL of distilled water were added. The reaction was then 
monitored with a ten-minute TLC with a 7:3 hexanes:ethyl acetate solvent system under 
254 nm ultra-violet (UV) light to establish the formation of a new compound (Figure 7D 
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2). The reaction was stirred for 10 more minutes at r.t., the solvent was stripped, and the 
crude was refrigerated.  
Synthesis of 2-(cyclopentylthio)-1,4-benzoquinone - Second Proposed Synthetic 
Approach - Step II 
 The crude from step I was dissolved with 12.5 mL of DCM and 2.5 mL of MeOH. 
In a separate reaction container, 1.069 g of sodium periodate were added to 5.00 mL of 
distilled water, and the mixture was added drop-wise to the main reaction vessel. The 
main reaction vessel was then stirred for 10 minutes at r.t. and the reaction was 
monitored with a ten-minute TLC using a 7:3 hexanes:ethyl acetate solvent system 
under 254 nm ultra-violet (UV) light to establish the formation of a new compound 
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Figure 9. First preparative TLC (500um 20x20cm) run with 7:3 
hexanes:ethyl acetate solvent to isolate 2-(cyclopentylthio)-1,4-
benzoquinone. Desired band indicated by black boxes.
(Figure 7D 3). The solid was extracted, and the dried crude was placed in a refrigerator 
for storage. One week later, the desired product was isolated using preparative TLC and 
a 7:3 hexanes:ethyl acetate solvent system (Figure 9). A second preparative TLC was 
run on the isolated compound using a 9:1 hexanes:ethyl acetate solvent system (Figure 
10), and the identity of the final product was later determined using 1H NMR.  
Synthesis of 2-(cyclopentylthio)-1,4-benzoquinone - Third Proposed Synthetic 
Approach 
 First, 0.072 g of sodium metal were added to 8.33 mL of 2-methyl-2-propanol 
(17), and the reaction was stirred under gentle heat until the sodium metal dissolved. 
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Figure 10. Second preparative TLC (500um 20x20cm) run with 9:1 
hexanes:ethyl acetate solvent to isolate 2-(cyclopentylthio)-1,4-
benzoquinone. Band  collected indicated by black boxes. The desired 
product may, in fact, have existed in the red band.
Then, 0.267 mL of the 97% cyclopentanethiol (13) were added to the reaction vessel, 
and the reaction was placed on the hot plate to stir for five minutes under gentle heat. 
Finally, 0.3564 g of 2-chloro-1,4-benzoquinone (19) were added to the reaction vessel, 
and the reaction was stirred at r.t. for one day. After refrigerating for a week, the crude 
was thawed, and 0.090 mL of distilled water were added to the reaction vessel. The 
reaction vessel was then stirred at 350 RPM for 30 minutes. At that time, a ten-minute 
TLC with a 9:1 hexanes:ethyl acetate solvent system was run to establish the formation 
of a new compound before the addition of water (Figure 7E 2) and after the addition of 
water (Figure 7E 3). One week later, the desired product was isolated using preparative 
TLC and a 9:1 hexanes:ethyl acetate solvent system (Figure 11) with a slight alteration 
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Figure 11. Preparative TLC (500um 20x20cm) run with 9:1 hexanes:ethyl 
acetate solvent to isolate 2-(cyclopentylthio)-1,4-benzoquinone. 
Unfortunately, the picture was taken after the desired bands were scraped 
off. The band collected was a light brown.
in procedure. During the spotting step of the preparative TLC procedure, the interaction 
between the product and the silica gel seemed to cause the silica gel to peel off the 
plate, so rather than spotting the entire amount, only a portion of the product was 
actually spotted onto the TLC plate limiting our ability to know exactly how much was 
applied. The identity of the final product was later determined using 1H NMR. 
Extraction Procedure 
 The reaction mixture is vacuum filtered through celite (diatomacious earth) in a 
fritted funnel to remove solid contaminants. 5 mL of H2O are used to rinse the celite. 
The aqueous layer is then washed three times with 5 mL of DCM. The non-polar layer is 
then extracted from the aqueous layer using a separatory funnel and dried with sodium 
sulfate, which is then vacuum filtered using a Buchner funnel. The solvent is then 
stripped under reduced pressure and heat (WG-HB03 Wilmad LabGlass Heat Bath) in a 
rotary evaporator (RE11 Buchi Rotavapor). 
Flash Chromatography Column Procedure 
 A flash chromatography column (Kontes 250 mL) is filled with 20 times the mass 
of the crude in silica gel (230-400 Mesh, Grade 60). The silica gel is then packed three 
times using the least polar component of the solvent system and a nitrogen gas 
propellant. The dried crude is dissolved in ~3 mL of DCM and 5 drops of MeOH. It is 
then mixed with 2 times its mass in silica gel and stripped again using the rotary 
evaporator. The crude/silica gel powder is added to a flash chromatography column on 
top of the packed silica gel, and small boluses of the solvent system are used in 
coordination with the nitrogen gas propellant to push the crude into the packed silica 
gel. Once the crude has entered the packed silica gel, 20 mL fractions are collected until 
all the product has been pushed through the column. A 10 minute TLC with the same 
solvent system is run to determine which fractions contain the desired compound. The 
desired fractions are collected and combined. The solvent is removed using the rotary 
evaporator. 
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Preparative TLC Procedure 
 The dried crude is dissolved in ~3 mL of DCM and 5 drops of MeOH. The entirety 
of the crude is then spotted in parallel lines running the length of the edge of a 
preparative TLC (500um 20x20cm) plate on two opposing ends about 1 cm away from 
the border. The plate is then lowered into a TLC vessel filled with 35 mL of solvent with 
the spotted side tilted towards the bottom. The TLC is left to run for about 15 minutes on 
one end. When the product travels about half the length of the plate, the plate is then 
flipped, 15 mL more of solvent are added, and the TLC is run for 15 more minutes. 
Once complete, the plate is withdrawn and the band containing the desired compound 
is scraped off the plate. The collected powder is flushed with 5 mL of 9:1 DCM:MeOH 
using a 10 mL syringe containing a filtration frit. The solvent is then removed using the 
rotovap. 
RESULTS 
 Final products were confirmed using 1H NMR (400 Hz Jeol FT-NMR). 1H NMR 
predictions were also created for each compound as a means of comparison with the 
actual 1H NMR findings. 
!14Figure 12. 1H NMR prediction for 2-(phenylthio)-1,4-benzoquinone
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Figure 12. 1H NMR prediction for 2-(phenylthio)-1,4-benzoquinone
Figure 13. Experimental 1H NMR findings for first step of initially proposed 
dual step approach to synthesizing 2-(phenylthio)-3H-phenothiazin-3-one. 
Demonstrates presence of 2-(phenylthio)-1,4-benzoquinone. 
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Figure 14. 1H NMR prediction for 2-(phenylthio)-3H-phenothiazin-3-one
Figure 15. Experimental 1H NMR findings for first step of initially proposed 
dual step approach to synthesizing 2-(phenylthio)-3H-phenothiazin-3-one. 
Demonstrates presence of 2-(phenylthio)-3H-phenothiazin-3-one.
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Figure 16. 1H NMR prediction for 2-(cyclopentylthio)-1,4-benzoquinone
Figure 17. Experimental 1H NMR findings for first step of initially proposed 
dual step approach to synthesizing 2-(cyclopentylthio)-3H-phenothiazin-3-
one. Data indicates presence of 1,4-benzoquinone.
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Figure 18. 1H NMR prediction for 2,5-(dicyclopentylthio)-1,4-benzoquinone
Figure 19. Experimental 1H NMR findings for second proposed approach to 
synthesizing 2-(cyclopentylthio)-1,4-benzoquinone. Data indicates 
presence of 2,5-(dicyclopentylthio)-1,4-benzoquinone.
DISCUSSION 
Synthesis of 2-(phenylthio)-3H-phenothiazin-3-one - Initially Proposed Dual Step 
Synthetic Approach - Step I 
 After completely isolating and purifying the target compound, 0.379 g remained. 
A comparison between the predicted 1H NMR results for 2-(phenylthio)-1,4-
benzoquinone (Figure 12) and the experimental 1H NMR results (Figure 13) indicate 
that the correct compound was indeed collected. This was confirmed by the fact that the 
three peaks between 6.75 ppm and 7.75 ppm in Figure 13 match up with the predicted 
peaks in Figure 12.  The percent yield of 2-(phenylthio)-1,4-benzoquinone (9) was 
70.1%. 
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Figure 20. Experimental 1H NMR findings for Third proposed approach to 
synthesizing 2-(cyclopentylthio)-1,4-benzoquinone. Data seems to indicate 
presence of 2,5-(dicyclopentylthio)-1,4-benzoquinone and a significant 
amount of thiocyclopentane.
Synthesis of 2-(phenylthio)-3H-phenothiazin-3-one - Initially Proposed Dual Step 
Synthetic Approach - Step II 
 After completely isolating and purifying the target compound, 0.0198 g remained. 
A comparison between the predicted 1H NMR results for 2-(phenylthio)-3H-
phenothiazin-3-one (Figure 14) and the experimental 1H NMR results (FIgure 15) 
indicate that the correct compound was indeed collected. This was confirmed by the fact 
that the three peaks between 6.50 ppm and 8.50 ppm in Figure 15 match up with the 
predicted peaks in Figure 14. The two peaks that most definitively indicate the correct 
compound are the two peaks between 6.50 ppm and 7.5 ppm in Figure 15. There were, 
however, a significant amount of contaminants. The yield of 2-(phenylthio)-3H-
phenothiazin-3-one (12) was somewhat lower than expected at 48.5%. A better job 
could have been done washing the compound with DCM to remove any ammonia, 
methanol, water, or acetone. Further care could have also been taken in employing the 
quantitative techniques that ensure the highest yield.  
Synthesis of 2-(cyclopentylthio)-3H-phenothiazin-3-one - Initially Proposed Dual 
Step Synthetic Approach - Step I 
 After attempting to completely isolate and purify the target compound, 0.111 g 
remained. A comparison between the predicted 1H NMR results for 2-
(cyclopentylthio)-1,4-benzoquinone (Figure 16) and the experimental 1H NMR data 
(Figure 17) indicates that no 2-(cyclopentylthio)-1,4-benzoquinone (14) existed in the 
target compound. The experimental 1H NMR data (Figure 17) seems to show several 
contaminants and a single peak around 7ppm that identifies the compound as 1,4-
benzoquinone (1). It also appears to be missing the essential peaks between 1 ppm and 
3 ppm seen in the predicted results. The percent yield of 1,4-benzoquinone (1) was 
41.1%. The failure to synthesize a new product may have occurred because 1,4-
benzoquinone (1) acts as a base to deprotonate cyclopentanethiol (13). 
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Synthesis of 2-(cyclopentylthio)-1,4-benzoquinone - Second Proposed Synthetic 
Approach 
 After completely isolating and purifying the target compound, 0.0591 g remained. 
A comparison between the predicted 1H NMR results for 2-(cyclopentylthio)-1,4-
benzoquinone (Figure 16) and the experimental 1H NMR findings (Figure 19) indicate 
the desired compound was not collected. The experimental 1H NMR findings (Figure 
19) reveal that there is second peak missing between 6 ppm and 7 ppm that would have 
existed in a 2:1 ratio with the neighboring peak. The single peak between 6 ppm and 7 
ppm suggests that we instead bis-alkylated the compound and now have 2,5-
(dicyclopentylthio)-1,4-benzoquinone (Figure 21) with a percent yield of 19.2%. This is 
confirmed by comparing the experimental 1H NMR findings (Figure 19) with the 
predicted 1H NMR results (Figure 18) for 2,5-dicyclopentanethio-1,4-benzoquinone 
(20).  
Synthesis of 2-(cyclopentylthio)-1,4-benzoquinone - Third Proposed Synthetic 
Approach 
 After completely isolating and purifying the target compound, 0.0238 g remained. 
An unknown portion of the product was applied to the plate limiting the ability to obtain a 
percent yield. A comparison between the predicted 1H NMR results for 2-
(cyclopentylthio)-1,4-benzoquinone (Figure 16) and the experimental 1H NMR findings 
(Figure 20) indicate the desired compound was not collected. The experimental 1H 
NMR findings (Figure 20) indicate, instead, the presence of 2,5-(dicyclopentylthio)-1,4-
benzoquinone (20), which is confirmed by consultation with the expected 1H NMR 
results for 2,5-(dicyclopentylthio)-1,4-benzoquinone (Figure 18). A significant amount of 
thiocyclopentane was also present. 
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Figure 21. 2,5-(dicyclopentylthio)-1,4-benzoquinone
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CONCLUSION 
 The current investigation into synthetic pathways for two 2-thio-substituted-3H-
phenothiazin-3-ones (7) successfully establishes a synthetic approach for 2-
(phenylthio)-3H-phenothiazin-3-one (12). The next step will be to determine whether this 
specific approach can be repeated on a larger scale. This investigation also contains 
significant work towards the synthesis of 2-(cyclopentylthio)-3H-phenothiazin-3-one 
(16). A successful synthetic approach has not yet been established for 2-
(cyclopentylthio)-3H-phenothiazin-3-one (16), but testing will continue to determine an 
efficient and effective pathway. One significant obstacle to this endeavor appears to be 
the inclination of 1,4-benzoquinone (1) to be bis-alkylated by the cyclopentanethiol (13). 
A proposed method for overcoming this obstacle is to adjust the molar ratio of 1,4-
benzoquinone (1) to cyclopentanethiol (13) from 1:1 to 3:1 while adding the 
cyclopentanethiol (13) drop-wise to the 1,4-benzoquinone (1) during the reaction. This 
would keep the 1,4-benzoquinone (1) from being overwhelmed by the cyclopentanethiol 
(13). Future work will also include finding synthetic pathways for new 2-thio-
substituted-3H-phenothiazin-3-ones (7) since our ultimate goal is to create a vast library 
of 2-thio-substituted-3H-phenothiazin-3-ones (7) for testing in inhibition of leukotrienes. 
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